Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

APB-102 Receives Orphan Drug Designation for Genetic SOD1 ALS Treatment

americanpharmaceuticalreviewJuly 23, 2019

Tag: Orphan Drug , Designation , Treatment

PharmaSources Customer Service